It was recently shown that treatments with neferine restrain the proliferation, migration, and invasion of breast cancer cells via downregulating miR-374a, which positively controls FGFR2 levels [22] (Figure 1 and Table 3). This evidence concerns the gene FGFR2 and breast carcinoma.